Norcliffe Capital
Investor profile
Venture capital
Norcliffe Capital has backed 3 European tech companies across 3 funding rounds between 2023 and 2025, joining rounds totalling €23M. Most active in Healthtech. Data as of 4 Nov 2026.
Deals
3
distinct rounds
Companies
3
backed
Active span
2023–2025
3 yrs
Total round €
€23M
sum of rounds joined
Deals by year
distinct rounds / yearNorcliffe Capital — deals by year — interactive chart.
Data table
| Norcliffe Capital — deals by year | |
|---|---|
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
Top sectors
by dealsNorcliffe Capital — top sectors — interactive chart.
Data table
| Norcliffe Capital — top sectors | |
|---|---|
| Healthtech | 3 |
Stages
by dealsNorcliffe Capital — stages — interactive chart.
Data table
| Norcliffe Capital — stages | |
|---|---|
| Seed | 2 |
| Series A | 1 |
Countries
by dealsNorcliffe Capital — countries — interactive chart.
Data table
| Norcliffe Capital — countries | |
|---|---|
| UK | 3 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Dxcover | UK | 1 | €11M |
| Laverock Therapeutics | UK | 1 | €7.6M |
| Glen Clova Scientific | UK | 1 | €4.7M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Dxcover | Series A | €11M | 2023-02 |
| Laverock Therapeutics | Seed | €7.6M | 2025-06 |
| Glen Clova Scientific | Seed | €4.7M | 2024-04 |